Yahoo Finance-Sep 1, 06:09 AM
SLS and IBRX rise in August as Eli Lilly's $2.9B deal fuels M&A expectations
SLS and IBRX shares gained in August following Eli Lilly's $2.9 billion acquisition. Retail traders anticipate a broader M&A rampage in the sector.